Akshaya Sudhakar
26 posts
Series in @CIDJournal of 22 immunocompromised patients with mostly omicron COVID-19 on various combinations of two antivirals +/- mAb. Outcomes good, possibly better with mAbs. Added to "COVID-19: Treatment" folder at transplantid.net academic.oup.com/cid/advance-ar…
Today in journal club, we discussed #DoxyPEP, which generated a lively discussion! #IDTwitter: how have you been deciding which patients to prescribe this for? Has anyone set up formal criteria they would like to share?
It has been well documented that #antimicrobial-resistant bacteria are much more common in countries and regions where health systems rely heavily on broad-spectrum antibiotics, @McMasterU’s @JeffPernica says. brighterworld.mcmaster.ca/articles/shige…
Retrospective Analysis of the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA™) Administered Under Enforcement Discretion to Patients with Clostridioides difficile Infection ✅ Just Accepted 🔓 Open Access 🔗 bit.ly/433xTop
Maternal vaccination was 82% effective in preventing medically attended RSV-associated lower respiratory tract illness in infants within 90 days after birth and 69% effective within 180 days. Full results of the MATISSE trial: nej.md/3Mc1hmg #InfectiousDisease
All studies comparing different beta-lactam options for P. aeruginosa bacteremia-directed monotherapy are retrospective 🆕️⚡️⚡️ @CMIJournal @davidvanduin Which trial do we need? How to treat Pseudomonas aeruginosa bacteremia -proposal for an umbrella RCT clinicalmicrobiologyandinfection.com/article/S1198-…
Rezafungin is the first new drug for the treatment of candidemia and invasive candidiasis in over a decade! Anidulafungin fda approved 2006 Are you excited about its approval? #IDTwitter
New Antifungals for Vulvovaginal Candidiasis: What Is Their Role? 🗨️ Invited Commentary 🔗 bit.ly/3ZThDE5
🆕️⚡️⚡️Quasi-experimental, prospective, multicentre, Before/after @CMIJournal Impact of selective reporting of antibiotic susceptibility testing results for UTIs in the outpatient setting ⬇️ prescription attributable to the ⬇️ in proportion of 3G ceph clinicalmicrobiologyandinfection.com/article/S1198-…
CDC has observed an increase in extensively drug-resistant shigellosis among some populations of adults. See our recommendations for diagnosing and managing these infections and steps patients can take to keep others healthy: bit.ly/3Y30EOk #AntimicrobialResistance
We need to discuss moving away from universal masking. I am on the fence about whether to keep masking during respiratory virus season, but I definitely don’t think this should be a year round thing. The reality is that COVID today is not what it was earlier in the pandemic.
From @STCmicrobeblog: Have you ever wondered what goes on inside a bacterium when it's attacked by a phage? Imagine an epic battle between two armies, like in "The Lord of the Rings" but seen through a microscope. asm.social/11V
Antibiotic Adjuvants for Combatting Antimicrobial Resistance by @madelinerb2 bit.ly/3JQeVdw "there are 3 major classes of adjuvants..β-lactamase inhibitors, efflux pump inhibitors (EPIs) and membrane permeabilizers, with the first showing the greatest clinical success"
